INSM stock news
This page provides real-time market news, earnings updates, and company announcements related to Insmed Incorporated (INSM).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-10 14:18 EST
Insmed Falls 5.56% as Death Cross and Broken Support Levels Signal Bearish Outlook to $133.80
101 finance2026-03-21 01:36:57
This $116 Million Purchase Accompanies a 360% Surge in Shares and Appears to Show Strong Confidence in a Major Drug Debut
101 finance2026-03-21 23:39:16
This Recent $193 Million Investment Focuses on a Biotech Firm Generating $689 Million in Revenue With Promising Turnaround Potential
101 finance2026-03-21 23:48:10
Insmed's ARIKAYCE MAC Label Broadening: An Affirmation Rather Than a Driver, While Brensocatib Takes Over the Story of Expansion
101 finance2026-03-23 11:27:40
Insmed’s $1 Billion Brinsupri Ambition: Has the Market Already Factored in a Short Squeeze?
101 finance2026-03-23 12:18:44
INSM Surges 10% in Pre-Market Silence
101 finance2026-03-23 12:24:52
Insmed's Chief Executive Offloads Large Number of Shares Following Encouraging Arikayce Results — Is This a Savvy Bearish Indicator?
101 finance2026-03-23 15:33:52
Insmed’s ARIKAYCE study meets anticipated outcomes—However, the focus for future expansion shifts to Brinsupri rather than ARIKAYCE
101 finance2026-03-23 20:12:49
Gilead's Targeted Purchase of Ouro Medicines Drives Volume to 110th Place Amid Growth of Autoimmune Drug Pipeline
101 finance2026-03-23 23:00:55
INSM shares rise following Arikayce's successful outcome in label expansion trial
101 finance2026-03-24 14:15:48
Insmed Shares Drop 3.36% as Trading Volume Falls to 303rd in Market Activity Despite Upcoming Label Expansion
101 finance2026-03-25 00:00:51
Insmed Ignites: Bulls Take Back $147 with a 6% Rally, Defying the Downturn
101 finance2026-03-25 16:54:52
INSM Surges 6.7%: The Hidden Japanese Market That Could Double Insmed's Addressable Universe
101 finance2026-03-25 19:06:46
Insmed's $162 Target Faces Overhang as Failed CRSsNP Trial Casts Shadow
101 finance2026-03-30 11:07:11
Insmed Surges 5.4% on Intraday Momentum: Is This the Start of a Breakout?
101 finance2026-03-30 14:15:58
The S&P 500 closed down 0.4% in preliminary trading, with the industrial sector falling 1.7%, the technology sector dropping 1.6%, the energy sector declining 0.7%, while the financial sector rose 1.1%.
华尔街见闻2026-03-30 20:03:08
Insmed Halts European Rollouts Amid US Pricing Uncertainty Stalling Pharmaceutical Innovation
101 finance2026-03-31 06:24:48
Insmed (INSM) Jumps 6.3%: What’s Driving This Biopharma Rally?
101 finance2026-03-31 19:00:51
Insmed’s technical indicators show mixed results while analysts remain optimistic
101 finance2026-04-01 01:42:40
Options Bulls Could Be Right About This Pharma Stock
Finviz2026-04-01 17:06:49
FSLR Experiences Death Cross Collapse as Bears Dominate Under Crucial $140 Moving Average
101 finance2026-04-06 09:12:43
Insmed announced that its latest study failed to meet both the predefined primary and secondary efficacy endpoints.
老虎证券2026-04-07 20:14:19
Insmed's unsuccessful HS trial reinforces expectations of disappointment—core operations remain the sole driver for growth
101 finance2026-04-07 20:51:42
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Finviz2026-04-09 20:06:07
Insmed’s $1 Billion Brinsupri Ambition: Has the Market Already Factored in a Short Squeeze?
101 finance2026-03-23 12:18:44
INSM Surges 10% in Pre-Market Silence
101 finance2026-03-23 12:24:52
Insmed's Chief Executive Offloads Large Number of Shares Following Encouraging Arikayce Results — Is This a Savvy Bearish Indicator?
101 finance2026-03-23 15:33:52
Insmed’s ARIKAYCE study meets anticipated outcomes—However, the focus for future expansion shifts to Brinsupri rather than ARIKAYCE
101 finance2026-03-23 20:12:49
Gilead's Targeted Purchase of Ouro Medicines Drives Volume to 110th Place Amid Growth of Autoimmune Drug Pipeline
101 finance2026-03-23 23:00:55
INSM shares rise following Arikayce's successful outcome in label expansion trial
101 finance2026-03-24 14:15:48
Insmed Shares Drop 3.36% as Trading Volume Falls to 303rd in Market Activity Despite Upcoming Label Expansion
101 finance2026-03-25 00:00:51
Insmed Ignites: Bulls Take Back $147 with a 6% Rally, Defying the Downturn
101 finance2026-03-25 16:54:52
INSM Surges 6.7%: The Hidden Japanese Market That Could Double Insmed's Addressable Universe
101 finance2026-03-25 19:06:46
Insmed's $162 Target Faces Overhang as Failed CRSsNP Trial Casts Shadow
101 finance2026-03-30 11:07:11
Insmed Surges 5.4% on Intraday Momentum: Is This the Start of a Breakout?
101 finance2026-03-30 14:15:58
The S&P 500 closed down 0.4% in preliminary trading, with the industrial sector falling 1.7%, the technology sector dropping 1.6%, the energy sector declining 0.7%, while the financial sector rose 1.1%.
华尔街见闻2026-03-30 20:03:08
Insmed Halts European Rollouts Amid US Pricing Uncertainty Stalling Pharmaceutical Innovation
101 finance2026-03-31 06:24:48
Insmed (INSM) Jumps 6.3%: What’s Driving This Biopharma Rally?
101 finance2026-03-31 19:00:51
Insmed’s technical indicators show mixed results while analysts remain optimistic
101 finance2026-04-01 01:42:40
Options Bulls Could Be Right About This Pharma Stock
Finviz2026-04-01 17:06:49
FSLR Experiences Death Cross Collapse as Bears Dominate Under Crucial $140 Moving Average
101 finance2026-04-06 09:12:43
Insmed announced that its latest study failed to meet both the predefined primary and secondary efficacy endpoints.
老虎证券2026-04-07 20:14:19
Insmed's unsuccessful HS trial reinforces expectations of disappointment—core operations remain the sole driver for growth
101 finance2026-04-07 20:51:42
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Finviz2026-04-09 20:06:07
INSM stock chart
INSM stock detailsINSM stock price change
On the last trading day, INSM stock closed at 160.18 USD, with a price change of -1.75% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more